{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:39:45Z","timestamp":1780504785382,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T00:00:00Z","timestamp":1422662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0336-5","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T14:43:50Z","timestamp":1422629030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2\u20133 diarrhoea"],"prefix":"10.1186","volume":"10","author":[{"given":"Tina","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Khazzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf\u2013Dieter","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,31]]},"reference":[{"key":"336_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"key":"336_CR2","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of german CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11\u00a0years. J Clin Oncol. 2012;30:1926\u201333.","journal-title":"J Clin Oncol"},{"key":"336_CR3","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Braendengen","year":"2008","unstructured":"Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, P\u00e5hlman L, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687\u201394.","journal-title":"J Clin Oncol"},{"key":"336_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114\u201323.","journal-title":"N Engl J Med"},{"key":"336_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jpainsymman.2007.10.007","volume":"36","author":"NI Cherny","year":"2008","unstructured":"Cherny NI. Evaluation and management of treatment-related diarrhea in patients with advanced cancer: A review. J Pain Symptom Manage. 2008;36:413\u201323.","journal-title":"J Pain Symptom Manage"},{"key":"336_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/02841860701317873","volume":"46","author":"A Gunnlaugsson","year":"2007","unstructured":"Gunnlaugsson A, Kjell\u00e9n E, Nilsson P, Bendahl PO, Willner J, Johnsson A. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol. 2007;46:937\u201344.","journal-title":"Acta Oncol"},{"key":"336_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","volume":"70","author":"JM Robertson","year":"2008","unstructured":"Robertson JM, Lockman D, Yan D, Wallace M. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70:413\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"336_CR8","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","volume":"76","author":"BD Kavanagh","year":"2010","unstructured":"Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76 Suppl 3:S101\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"336_CR9","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76 Suppl 3:S10\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR10","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ijrobp.2006.07.005","volume":"66","author":"RD Hofheinz","year":"2006","unstructured":"Hofheinz RD, Horisberger K, Woernle C, Wenz F, Kraus-Tiefenbacher U, K\u00e4hler G, et al. Phase I trial of Cetuximab in combination with Capecitabine, weekly Irinotecan and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2006;66:1384\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2008.10.014","volume":"74","author":"K Horisberger","year":"2009","unstructured":"Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Str\u00f6bel P, et al. Cetuximab in combination with Capecitabine, Irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a phase II Margit trial. Int J Radiat Oncology Biol Phys. 2009;74:1487\u201393.","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"W Youden","year":"1950","unstructured":"Youden W. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"336_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","volume":"52","author":"KL Baglan","year":"2002","unstructured":"Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002;52:176\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR14","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP Gerard","year":"2006","unstructured":"Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent Fluoruracil and Leucovorin in T3-4 rectal cancers: results of FFCD9203. J Clin Oncol. 2006;24:4620\u20135.","journal-title":"J Clin Oncol"},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","volume":"23","author":"JF Bosset","year":"2005","unstructured":"Bosset JF, Mineur CL, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol. 2005;23:5620\u20137.","journal-title":"J Clin Oncol"},{"key":"336_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","volume":"13","author":"RD Hofheinz","year":"2012","unstructured":"Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol. 2012;13:579\u201388.","journal-title":"Lancet Oncol."},{"key":"336_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","volume":"32","author":"MJ O\u2019Connell","year":"2014","unstructured":"O\u2019Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, et al. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04. J Clin Oncol. 2014;32:1927\u201334.","journal-title":"J Clin Oncol"},{"key":"336_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00066-008-1751-4","volume":"184","author":"J Dunst","year":"2008","unstructured":"Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, et al. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol. 2008;184:450\u20136.","journal-title":"Strahlenther Onkol"},{"key":"336_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijrobp.2006.08.063","volume":"67","author":"DY Kim","year":"2007","unstructured":"Kim DY, Jung KH, Kim TH, Kim DW, Chang HJ, Jeong JY, et al. Comparison of 5-fluorouracil\/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67:378\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/annonc\/mdl268","volume":"17","author":"A Paoli De","year":"2006","unstructured":"De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol. 2006;17:247\u201351.","journal-title":"Ann Oncol"},{"key":"336_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10637-008-9192-6","volume":"27","author":"L Ugidos","year":"2009","unstructured":"Ugidos L, Delgado S, Conill C, Gin\u00e9s A, Gallego R, Ayuso JR, et al. Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients. Invest New Drugs. 2009;27:262\u20138.","journal-title":"Invest New Drugs"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/sj.bjc.6603645","volume":"96","author":"F Willeke","year":"2007","unstructured":"Willeke F, Horisberger K, Kraus-Tiefenbacher U, Wenz F, Leitner A, Hochhaus A, et al. A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (Caplri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer. 2007;96:912\u20137.","journal-title":"Br J Cancer"},{"key":"336_CR23","unstructured":"Sebag-Montefiore, D (2008). ARISTOTLE: Advanced rectal study with standard therapy or a novel agent. Total mesorectal excision (TME) and long term evaluation. Current controlled trials. \n                    http:\/\/www.isrctn.com\/ISRCTN09351447\n                    \n                  ."},{"key":"336_CR24","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1200\/JCO.2011.39.6036","volume":"30","author":"A Dewdney","year":"2012","unstructured":"Dewdney A, Cunningham D, Tabernero J, Capdevila J, Glimelius B, Cervantes A, et al. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol. 2012;30:1620\u20137.","journal-title":"J Clin Oncol"},{"key":"336_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/jso.21993","volume":"104","author":"JK Lin","year":"2011","unstructured":"Lin JK, Lin AJ, Lin CC, Lan YT, Yang SH, Li AF, et al. The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy. J Surg Oncol. 2011;104:661\u20136.","journal-title":"J Surg Oncol"},{"key":"336_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00066-003-1078-0","volume":"179","author":"J Willner","year":"2003","unstructured":"Willner J, Jost A, Baier K, Flentje M. A little to a Lot or a Lot to a little? an analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol. 2003;179:548\u201356.","journal-title":"Strahlenther Onkol"},{"key":"336_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0360-3016(97)00764-5","volume":"40","author":"SJ Huh","year":"1998","unstructured":"Huh SJ, Lim DH, Ahn YC, Kim DY, Kim MK, Wu HG, et al. Effect of customized small bowel displacement system in pelvic irradiation. Int JRadiat Oncol Biol Phys. 1998;40:623\u20137.","journal-title":"Int JRadiat Oncol Biol Phys"},{"key":"336_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0360-3016(99)00345-4","volume":"45","author":"O Koelbl","year":"1999","unstructured":"Koelbl O, Richter S, Flentje M. Influence of patient positioning on dosevolume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 1999;45:1193\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0360-3016(90)90559-3","volume":"19","author":"TG Shanahan","year":"1990","unstructured":"Shanahan TG, Mehta MP, Bertelrud KL, Buchler DA, Frank LE, Gehring MA, et al. Minimization of small bowel volume within treatment fields utilizing customized \u201cbelly boards\u201d. Int J Radiat Oncol Biol Phys. 1990;19:469\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","volume":"52","author":"AJ Mundt","year":"2002","unstructured":"Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52:1330\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijrobp.2005.05.052","volume":"63","author":"YJ Chen","year":"2005","unstructured":"Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, et al. Organ sparing by conformal avoidance intensity -modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal\/femoral nodes. Int J Radiat Oncol Biol Phys. 2005;63:274\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"336_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-2-41","volume":"2","author":"C Menkarios","year":"2007","unstructured":"Menkarios C, Azria D, Lalibert\u00e9 B, Moscardo CL, Gourgou S, Lemanski C, et al. Optimal organ-sparing intensity modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol. 2007;2:41.","journal-title":"Radiat Oncol"},{"key":"336_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.radonc.2011.10.018","volume":"102","author":"HA Wolff","year":"2012","unstructured":"Wolff HA, Wagner DM, Conradi LC, Hennies S, Ghadimi M, Hess CF, et al. Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications. Radiother Oncol. 2012;102:30\u20137.","journal-title":"Radiother Oncol"},{"key":"336_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1748-717X-6-63","volume":"6","author":"H Mok","year":"2011","unstructured":"Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, et al. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011;6:63.","journal-title":"Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0336-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-015-0336-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0336-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0336-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:41:57Z","timestamp":1553640117000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-015-0336-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0336-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,31]]},"assertion":[{"value":"5 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}